IDEXX Q2 FY26 EPS rises 18% to $4.27; revenue increases 10% to USD 1.22 billion - IDXX News | RalliesIDEXX Q2 FY26 EPS rises 18% to $4.27; revenue increases 10% to USD 1.22 billion
I
IDXX• Q2 results and full-year outlook
- IDEXX Laboratories posted Q2 2026 revenue of $1.22 billion, up 10% year over year; diluted EPS climbed 18% to $4.27.
- Operating margin widened 1.4 percentage points to 35%; net income attributable to stockholders rose to $338.41 million.
- Companion Animal Group revenue increased 9% to $1.12 billion; Diagnostics recurring revenue rose 11% to $974.71 million.
- Water revenue advanced 15% to $58.56 million, while LPD revenue grew 11% to $35.18 million.
- Full-year revenue outlook was updated to $4.7 billion-$4.75 billion; EPS forecast lifted to $14.69-$14.94.
WILC
•
